{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-23-000004","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.590936+00:00","generated_at":"2026-06-20T17:13:32.751520+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Clover Health appoints Jamie Reynoso as CEO of Medicare Advantage and issues FY2023 partial guidance","bullets":["Appointed Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage, effective January 6, 2023.","Issued partial FY2023 guidance: Insurance revenue $1.15B-$1.20B, Insurance MCR 89%-91%.","Andrew Toy to present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023.","Non-Insurance revenue guidance $0.75B-$0.80B, Non-Insurance MCR 98%-100%.","Strategic shift to prioritize profitability, expecting favorability in 2023 MCR and growth in Insurance top-line revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-23-000004","json":"https://secwatch.observer/filing/0001801170-23-000004.json","markdown":"https://secwatch.observer/filing/0001801170-23-000004.md","text":"https://secwatch.observer/filing/0001801170-23-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/0001801170-23-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/clov-20230106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:13:32.751520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63eca38be2","claim":"Jamie L. Reynoso was appointed as Chief Executive Officer of Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"On January 6, 2023, the Board of Directors of Clover Health Investments, Corp. (the \" Company \") appointed Jamie L. Reynoso Chief Executive Officer of Medicare Advantage, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/0001801170-23-000004-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer of Medicare Advantage"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}